000 01182 a2200301 4500
005 20250513034350.0
264 0 _c19950830
008 199508s 0 0 eng d
022 _a0268-1315
024 7 _a10.1097/00004850-199503000-00002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStein, D J
245 0 0 _aMeta-analysis of pharmacotherapy trials for obsessive-compulsive disorder.
_h[electronic resource]
260 _bInternational clinical psychopharmacology
_cMar 1995
300 _a11-8 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis
650 0 4 _aAnalysis of Variance
650 0 4 _aHumans
650 0 4 _aObsessive-Compulsive Disorder
_xdrug therapy
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPsychotropic Drugs
_xadministration & dosage
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xtherapeutic use
700 1 _aSpadaccini, E
700 1 _aHollander, E
773 0 _tInternational clinical psychopharmacology
_gvol. 10
_gno. 1
_gp. 11-8
856 4 0 _uhttps://doi.org/10.1097/00004850-199503000-00002
_zAvailable from publisher's website
999 _c7622237
_d7622237